247 related articles for article (PubMed ID: 20712376)
21. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.
Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O
PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863
[TBL] [Abstract][Full Text] [Related]
22. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
23. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
24. The solution structure of the anti-HIV chemokine vMIP-II.
Liwang AC; Wang ZX; Sun Y; Peiper SC; Liwang PJ
Protein Sci; 1999 Nov; 8(11):2270-80. PubMed ID: 10595530
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus.
Heidarieh H; Alcamí A
J Biol Chem; 2018 Nov; 293(45):17418-17429. PubMed ID: 30257868
[TBL] [Abstract][Full Text] [Related]
26. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C
Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.
Severin IC; Gaudry JP; Johnson Z; Kungl A; Jansma A; Gesslbauer B; Mulloy B; Power C; Proudfoot AE; Handel T
J Biol Chem; 2010 Jun; 285(23):17713-24. PubMed ID: 20363748
[TBL] [Abstract][Full Text] [Related]
28. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
[TBL] [Abstract][Full Text] [Related]
29. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
Kledal TN; Rosenkilde MM; Coulin F; Simmons G; Johnsen AH; Alouani S; Power CA; Lüttichau HR; Gerstoft J; Clapham PR; Clark-Lewis I; Wells TN; Schwartz TW
Science; 1997 Sep; 277(5332):1656-9. PubMed ID: 9287217
[TBL] [Abstract][Full Text] [Related]
30. A model of GAG/MIP-2/CXCR2 interfaces and its functional effects.
Rajasekaran D; Keeler C; Syed MA; Jones MC; Harrison JK; Wu D; Bhandari V; Hodsdon ME; Lolis EJ
Biochemistry; 2012 Jul; 51(28):5642-54. PubMed ID: 22686371
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.
Boshoff C; Endo Y; Collins PD; Takeuchi Y; Reeves JD; Schweickart VL; Siani MA; Sasaki T; Williams TJ; Gray PW; Moore PS; Chang Y; Weiss RA
Science; 1997 Oct; 278(5336):290-4. PubMed ID: 9323208
[TBL] [Abstract][Full Text] [Related]
32. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.
Seet BT; Barrett J; Robichaud J; Shilton B; Singh R; McFadden G
J Biol Chem; 2001 Aug; 276(32):30504-13. PubMed ID: 11369757
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional analysis of the RANTES-glycosaminoglycans interactions.
Martin L; Blanpain C; Garnier P; Wittamer V; Parmentier M; Vita C
Biochemistry; 2001 May; 40(21):6303-18. PubMed ID: 11371192
[TBL] [Abstract][Full Text] [Related]
34. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
Penk A; Baumann L; Huster D; Samsonov SA
Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
[TBL] [Abstract][Full Text] [Related]
35. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
Ziarek JJ; Veldkamp CT; Zhang F; Murray NJ; Kartz GA; Liang X; Su J; Baker JE; Linhardt RJ; Volkman BF
J Biol Chem; 2013 Jan; 288(1):737-46. PubMed ID: 23148226
[TBL] [Abstract][Full Text] [Related]
36. Chapter 4. Interactions of chemokines with glycosaminoglycans.
Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
[TBL] [Abstract][Full Text] [Related]
37. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.
Stine JT; Wood C; Hill M; Epp A; Raport CJ; Schweickart VL; Endo Y; Sasaki T; Simmons G; Boshoff C; Clapham P; Chang Y; Moore P; Gray PW; Chantry D
Blood; 2000 Feb; 95(4):1151-7. PubMed ID: 10666184
[TBL] [Abstract][Full Text] [Related]
38. Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer.
Fox JC; Tyler RC; Peterson FC; Dyer DP; Zhang F; Linhardt RJ; Handel TM; Volkman BF
Biochemistry; 2016 Mar; 55(8):1214-25. PubMed ID: 26836755
[TBL] [Abstract][Full Text] [Related]
39. NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27.
Jansma AL; Kirkpatrick JP; Hsu AR; Handel TM; Nietlispach D
J Biol Chem; 2010 May; 285(19):14424-37. PubMed ID: 20200157
[TBL] [Abstract][Full Text] [Related]
40. Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10).
Crump MP; Elisseeva E; Gong J; Clark-Lewis I; Sykes BD
FEBS Lett; 2001 Feb; 489(2-3):171-5. PubMed ID: 11165244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
